Every S-1 that Laser Photonics Corp (LASE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow LASE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LASE filings page.
Laser Photonics Corp (LASE) filed Amendment No. 2 to its Form S-1 registration statement, Registration No. 333-298783, on September 9, 2026. The amendment primarily updates legal opinion Exhibit 5.1 to include the maximum number of shares of common stock and warrants covered by the registration.
The filing also refreshes the exhibit index and confirms signatures and powers of attorney for interim president Ann Tewari, acting chief financial officer Timothy A. Peterman, and directors Tim Miller, Troy Parkos, and Qing Lu, authorizing them to sign further amendments and related Rule 462(b) filings.
Laser Photonics Corp (symbol LASE) filed Amendment No. 1 to its Form S-1 registration statement to update the prospectus primarily through incorporation by reference of recent SEC filings. The amendment specifically adds the Form 8-K filed September 8, 2026, which reports the engagement of Timothy A. Peterman as Acting Chief Financial Officer, and includes new auditor consent exhibits from M&K CPAS, PLLC and Weinberg & Company covering the company’s audited financial statements for the years ended December 31, 2024 and December 31, 2025. The document also confirms a broad exhibit index and grants Interim President Ann Tewari power of attorney to sign further amendments and related registration statements on behalf of the company’s officers and directors.
Laser Photonics Corporation (LASE) has filed a Form S-1 to raise capital through a best-efforts primary offering of up to 7,142,857 shares of common stock, with matching amounts of pre-funded warrants and common warrants, plus placement agent warrants. The assumed combined price is $1.40 per share and accompanying warrants, implying estimated net proceeds of about $9.1 million if fully placed. Shares outstanding would rise from 50.2 million to 57.3 million before any warrant exercises, and the company estimates new investors would face dilution of about $1.24 per share at that price. Proceeds are earmarked approximately 40% for R&D, 35% for strategic acquisitions, and 25% for working capital.
The company generated $8.3 million in 2025 sales but recorded a $17.5 million net loss and its auditor issued a going concern opinion. For the six months ended June 30, 2026, sales fell 44.3% year over year to $2.7 million, with a $6.2 million net loss, cash of $2.2 million, and a working capital deficit of $3.1 million. The structure adds significant warrant overhang and multiple inducement and exchange transactions, while a major stockholder group tied to ICT Investments controls around one-fifth of the common stock post-offering, giving it substantial influence over corporate decisions.
Laser Photonics Corporation is registering up to 5,234,144 shares of common stock for resale by existing security holders. The shares consist of 5,057,144 shares underlying Series A-7 and Series A-8 warrants issued in a July 16, 2026 Warrant Inducement Agreement and 234,058 shares underlying placement agent warrants issued to H.C. Wainwright & Co. designees.
The company will receive no proceeds from resale of these shares; it may receive cash only if the $0.975 per share Common Warrants and related placement agent warrants are exercised for cash, in which case any proceeds are earmarked for working capital and general corporate purposes. As of July 21, 2026, common stock outstanding was 47,584,492 shares
Laser Photonics is a vertically integrated manufacturer of photonics-based industrial systems, including laser blasting and cleaning solutions for automotive, aerospace, shipbuilding, and other sectors. Sales were $8.3 million for 2025 compared with $3.4 million for 2024, while net sales for the first quarter of 2026 were $0.9 million versus $2.3 million a year earlier, reflecting lower equipment deliveries and project timing. Growth initiatives include defense-related anti-drone systems, the Service Partner Network for small and medium businesses, and acquisitions such as Control Micro Systems and Beamer Laser to expand into pharmaceutical and industrial laser-marking markets.
Laser Photonics Corporation is registering up to 11,830,226 shares of common stock for resale by existing security holders. The shares consist of 4,742,860 underlying Series A-5 warrants, 6,687,310 underlying Series A-6 warrants, and 400,056 underlying placement agent warrants, all with an exercise price of $0.975 per share. The warrants become exercisable beginning on June 26, 2026 and have terms of five years (Series A-5 and related placement agent warrants) or 24 months (Series A-6) after the later of that date and the effectiveness of this registration. The company will not receive proceeds from any resales by the selling stockholders, but may receive cash if the warrants are exercised. Common stock was 47,647,622 shares outstanding as of June 23, 2026. Laser Photonics reported $8.3 million in sales for 2025 versus $3.4 million in 2024 and first-quarter 2026 net sales of $0.9 million versus $2.3 million a year earlier.
Laser Photonics Corporation is registering 2,900,472 shares of common stock for resale by existing security holders. These shares consist of 2,747,260 shares issuable upon exercise of Series A-3 and A-4 inducement warrants and 153,212 shares issuable upon exercise of placement agent warrants.
The company will not receive proceeds from any resale of these shares, but may receive cash if the warrants are exercised for cash at an exercise price of $1.08 per share. As of March 31, 2026, 32,544,703 shares of common stock were outstanding, and the stock last traded at $0.97 per share on April 23, 2026.
Laser Photonics Corporation is registering up to 4,716,981 shares of common stock, matching pre-funded warrants, and common warrants, plus additional shares underlying those warrants and placement agent warrants, in a best-efforts public offering led by H.C. Wainwright & Co.
The assumed public offering price is $2.12 per share and accompanying warrants, with estimated net proceeds of about $9 million. The company plans to use the cash for laser R&D, acquisitions, working capital, and to repay high-cost short-term notes issued in September 2025, including default premiums. There is no minimum offering amount and no escrow, so investors may fund the company even if only a portion of the securities are sold.
Laser Photonics reported 2024 revenue of $1.93 million and a net loss of $2.52 million, and a net loss of $8.11 million for the nine months ended September 30, 2025; its auditors raised substantial doubt about its ability to continue as a going concern. Investors face significant dilution, highly speculative warrant securities, and concentrated control, as ICT Investments and affiliates are expected to hold a majority of voting power after the offering.
Laser Photonics Corporation is filing an S-1 to offer shares of common stock, pre-funded warrants and common warrants on a best-efforts basis, with no minimum raise required. The securities are sold together at a fixed price, and the company will receive all proceeds, which it plans to use for laser technology R&D, acquisitions, working capital and repayment of short-term notes.
The common warrants become exercisable after stockholder approval unless specific Nasdaq pricing conditions are met, while pre-funded warrants are structured to keep holders below 4.99% or 9.99% ownership thresholds. The company highlights recent acquisitions in pharmaceutical laser systems and industrial laser marking, and notes significant related-party licensing with ICT Investments and affiliates, which will continue to control a majority of voting power.
Laser Photonics reports a net loss of $2,518,827 for 2024 and a net loss of $8,110,233 for the nine months ended September 30, 2025, and its auditors issued a going concern qualification. A portion of proceeds is earmarked to repay approximately $3.2 million tied to short-term notes and a dispute settlement with prior financing participants, underscoring the importance of this capital raise to its liquidity.
Laser Photonics Corporation (LASE) filed an S-1/A to register up to 3,871,964 shares of common stock for resale by selling stockholders. The registered shares include stock issued in a September 2025 private placement, shares issuable upon exercise of Series A and Series B common warrants, placement agent warrants, and shares and warrants issued to Hudson Global Ventures under an August 2025 financing.
The company will not receive proceeds from sales by the selling stockholders. It may receive cash only if the common warrants or the Hudson warrant are exercised for cash. The common warrants have a $3.40 exercise price; the Hudson warrant is at $4.34, and placement agent warrants are at $4.55. Certain warrants are subject to a 4.99% (or 9.99%) beneficial ownership cap.
Shares outstanding were 21,111,302 as of October 14, 2025. LASE last traded at $4.01 on October 20, 2025. The prospectus permits resales through various transaction types described in the Plan of Distribution.
Laser Photonics Corporation (LASE) filed a resale S-1 registering up to 3,871,964 shares of common stock for offer and sale by selling stockholders. The company is not selling any shares in this registration and will not receive proceeds from stockholder sales. It may receive cash proceeds only if certain warrants are exercised for cash.
The registered shares include 1,098,902 already issued in a September 2025 private placement, up to 2,197,804 issuable upon exercise of Series A and Series B warrants, 76,923 issuable under placement agent warrants, 418,000 commitment shares issued to Hudson Global Ventures, and up to 157,258 issuable under a Hudson warrant. The Common Warrants have a $3.40 exercise price; the Hudson Warrant has a $4.34 exercise price. Warrant exercises are subject to a 4.99% (or 9.99% at holder election) beneficial ownership cap.
Shares outstanding were 22,477,567 as of October 8, 2025. Any cash received from warrant exercises is described for inventory purchases, festival artist costs, transaction costs, expanded sales and marketing, partial prepayment of a note, and working capital. Context: these shares stem from a September 2025 private placement (approximately $4 million gross proceeds) and an August 2025 Hudson Global financing.